The production and characteristics of solid lipid nanoparticles (SLNs)

被引:333
作者
Hou, DZ
Xie, CS [1 ]
Huang, KJ
Zhu, CH
机构
[1] Huazhong Univ Sci & Technol, Dept Mat Sci & Engn, Wuhan 430074, Peoples R China
[2] Huazhong Univ Sci & Technol, Fac Mat Sci, Nano Pharmaceut Res Ctr, Wuhan 430074, Peoples R China
[3] Huazhong Univ Sci & Technol, TongJi Med Coll, Wuhan 430022, Peoples R China
关键词
modified high shear homogenization and ultrasound techniques; solid lipid nanoparticles; entrapment efficiency; laser diffractometry;
D O I
10.1016/S0142-9612(02)00578-1
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Modified high shear homogenization and ultrasound techniques were employed to produce solid lipid nanoparticles (SLNs). Model drug mifepristone had been incorporated in SLNs. The mean particle size measured by laser diffractometry (LD) was found to be 106 nm with a narrow particle distribution of polydispersity index, 0.278. Differential scanning calorimetry and X-ray diffraction measurements suggested that the majority of the SLNs were less ordered arrangement of crystals, and this was favorable for increasing the drug loading capacity. The drug entrapment efficiency (EE%) of SLNs was more than 87 percent and showed relatively long-term physical stability as the leakage was very small after being stored for one month. Therefore, seemed this modified method could prepare high quality SLNs loading lipophilic drugs. It is a simple, available and effective method to produce SLNs. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1781 / 1785
页数:5
相关论文
共 25 条
[1]   Vesicle-to-micelle transformation in systems containing dimeric surfactants [J].
Danino, D ;
Talmon, Y ;
Zana, R .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1997, 185 (01) :84-93
[2]  
de Vringer T, 1999, United States Patent, Patent No. [5904932, US 5904932]
[3]  
Gasco M. R., 1993, US Patent No, Patent No. [USS188837, 188837]
[4]   Lipophilic drug derivatives in liposomes [J].
Gulati, M ;
Grover, M ;
Singh, S ;
Singh, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (02) :129-168
[5]  
JENNING V, 2000, EUR J PHARM BIOPHARM, V50, P189
[6]   Gaulin homogenization: A mechanistic study [J].
Lander, R ;
Manger, W ;
Scouloudis, M ;
Ku, A ;
Davis, C ;
Lee, A .
BIOTECHNOLOGY PROGRESS, 2000, 16 (01) :80-85
[7]   Influence of high pressure homogenisation equipment on nanodispersions characteristics [J].
Liedtke, S ;
Wissing, S ;
Müller, RH ;
Mäder, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (02) :183-185
[8]  
LIVERSIDGE CC, 1996, INT S CONTROL REL BI, V23, P74
[9]  
Liversidge G.C., 1995, INT J PHARMACEUT, V127, P91
[10]  
Muller R., 1993, Proc. Int. Symp. Control Rel Bioact Mater, V20, P480